Cristina Elena Niturad,Dorit Lev,Vera M Kalscheuer,Agnieszka Charzewska,Julian Schubert,Tally Lerman-Sagie,Hester Y Kroes,Renske Oegema,Monica Traverso,Nicola Specchio,Maria Lassota,Jamel Chelly,Odeya Bennett-Back,Nirit Carmi,Tal Koffler-Brill,Michele Iacomino,Marina Trivisano,Giuseppe Capovilla,Pasquale Striano,Magdalena Nawara,Sylwia Rzonca,Ute Fischer,Melanie Bienek,Corinna Jensen,Hao Hu,Holger Thiele,Janine Altmüller,Roland Krause,Patrick May,Felicitas Becker,Rudi Balling,Saskia Biskup,Stefan A Haas,Peter Nürnberg,Koen L I van Gassen,Holger Lerche,Federico Zara,Snezana Maljevic,Esther Leshinsky-Silver

Abstract:Genetic epilepsies are caused by mutations in a range of different genes, many of them encoding ion channels, receptors or transporters. While the number of detected variants and genes increased dramatically in the recent years, pleiotropic effects have also been recognized, revealing that clinical syndromes with various degrees of severity arise from a single gene, a single mutation, or from different mutations showing similar functional defects. Accordingly, several genes coding for GABAA receptor subunits have been linked to a spectrum of benign to severe epileptic disorders and it was shown that a loss of function presents the major correlated pathomechanism. Here, we identified six variants in GABRA3 encoding the α3-subunit of the GABAA receptor. This gene is located on chromosome Xq28 and has not been previously associated with human disease. Five missense variants and one microduplication were detected in four families and two sporadic cases presenting with a range of epileptic seizure types, a varying degree of intellectual disability and developmental delay, sometimes with dysmorphic features or nystagmus. The variants co-segregated mostly but not completely with the phenotype in the families, indicating in some cases incomplete penetrance, involvement of other genes, or presence of phenocopies. Overall, males were more severely affected and there were three asymptomatic female mutation carriers compared to only one male without a clinical phenotype. X-chromosome inactivation studies could not explain the phenotypic variability in females. Three detected missense variants are localized in the extracellular GABA-binding NH2-terminus, one in the M2-M3 linker and one in the M4 transmembrane segment of the α3-subunit. Functional studies in Xenopus laevis oocytes revealed a variable but significant reduction of GABA-evoked anion currents for all mutants compared to wild-type receptors. The degree of current reduction correlated partially with the phenotype. The microduplication disrupted GABRA3 expression in fibroblasts of the affected patient. In summary, our results reveal that rare loss-of-function variants in GABRA3 increase the risk for a varying combination of epilepsy, intellectual disability/developmental delay and dysmorphic features, presenting in some pedigrees with an X-linked inheritance pattern.

Molecular Modelling of nsSNPs in GABRA2 Gene in Epilepsy and Study of Their Impact On Structure and Stability of GABRA2 Protein

Neurobiology of Disease Subunit Susceptibility Variants E 177 A and R 220 H Associated with Complex Epilepsy Alter Channel Gating and Surface Expression of 4 2 GABAA Receptors

Structural analysis of pathogenic missense mutations in GABRA2 and identification of a novel de novo variant in the desensitization gate

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Identification of 3'-UTR single nucleotide variants and prediction of select protein imbalance in mesial temporal lobe epilepsy patients

Structural Consequences of IRS-2 nsSNPs and Implication for Insulin Receptor Substrate-2 Protein Stability

Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.

Expansion of the Mutation and Phenotype Spectrum of the GABRA2-related Developmental and Epileptic Encephalopathy78

Molecular Insights into the Role of Pathogenic Nssnps in GRIN2B Gene Provoking Neurodevelopmental Disorders

GABRA1-Related Disorders: From Genetic to Functional Pathways

Algorithmic assessment reveals functional implications of GABRD gene variants linked to idiopathic generalized epilepsy

De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy

Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene

Analysis of Alzheimer's disease associated deleterious non-synonymous single nucleotide polymorphisms and their impacts on protein structure and function by performing in-silico methods

Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants

Exploring the Structural and Functional Effects of Nonsynonymous SNPs in the Human Serotonin Transporter Gene Through In Silico Approaches

Atomistic simulations reveal impacts of missense mutations on the structure and function of SynGAP1

Array-Comparative Genomic Hybridization Analysis of a Cohort of Saudi Patients with Epilepsy

Computational Identification and Functional Analysis of Potentially Pathogenic nsSNPs in the NLRP3 Gene Linked to Alzheimer's Disease

Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouse*

Using Structural Analysis to Clarify the Impact of Single Nucleotide Variants in Neurexin/neuroligin Revealed in Clinical Genomic Sequencing